RIA
SPPI

Realta Investment Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Realta Investment Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-100
Closed – – 1843
2019
Q2 		$0 Buy
+100
New +$894 ﹤0.01% 1834

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Realta Investment Advisors's SPPI Position: Q3 2019 in Review

Realta Investment Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2019, closing a stake of 100 shares.

Realta Investment Advisors first reported a position in SPPI in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 167 funds tracked by Wall St. Rank hold SPPI as of Q3 2019.

  • Realta Investment Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
  • Realta Investment Advisors sold 100 Spectrum Pharmaceuticals Inc shares in Q3 2019.
  • Realta Investment Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2019 and held it in 1 quarter.
  • Realta Investment Advisors's Spectrum Pharmaceuticals Inc position peaked at $0 in Q2 2019.
  • 167 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2019.

Based on Realta Investment Advisors's 13F filing for Q3 2019, filed 18 Oct 2019.